223 related articles for article (PubMed ID: 35168610)
1. Clinical significance of initial treatment for peritoneal lavage cytology-positive gastric cancer: outcomes according to treatment strategy.
Yago A; Haruta S; Ueno M; Ogawa Y; Shimoyama H; Ohkura Y; Udagawa H
World J Surg Oncol; 2022 Feb; 20(1):35. PubMed ID: 35168610
[TBL] [Abstract][Full Text] [Related]
2. Conversion therapy for peritoneal lavage cytology-positive type 4 and large type 3 gastric cancer patients selected as candidates for R0 resection by diagnostic staging laparoscopy.
Yasufuku I; Nunobe S; Ida S; Kumagai K; Ohashi M; Hiki N; Sano T
Gastric Cancer; 2020 Mar; 23(2):319-327. PubMed ID: 31350702
[TBL] [Abstract][Full Text] [Related]
3. [Application of laparoscopic exploration combined with abdominal exfoliative cytology in the diagnosis and treatment of locally advanced gastric cancer].
Ding PA; Liu Y; Guo HH; Yang PG; Tian Y; Fan LQ; Tan BB; Li Y; Zhao Q
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Feb; 23(2):170-176. PubMed ID: 32074798
[No Abstract] [Full Text] [Related]
4. Efficacy of chemotherapy versus surgery as initial treatment for gastric cancer with positive peritoneal cytology.
Li B; Miao R; Shan F; Li S; Jia Y; Xue K; Li Z; Ying X; Pang F; Zhang Y; Ji J; Li Z
World J Surg Oncol; 2023 Jul; 21(1):204. PubMed ID: 37434202
[TBL] [Abstract][Full Text] [Related]
5. Surgery after intraperitoneal and systemic chemotherapy for gastric cancer with peritoneal metastasis or positive peritoneal cytology findings.
Ishigami H; Yamaguchi H; Yamashita H; Asakage M; Kitayama J
Gastric Cancer; 2017 Mar; 20(Suppl 1):128-134. PubMed ID: 28028665
[TBL] [Abstract][Full Text] [Related]
6. Clinical impact of gastrectomy for gastric cancer patients with positive lavage cytology without gross peritoneal dissemination.
Kobayashi H; Honda M; Kawamura H; Takiguchi K; Muto A; Yamazaki S; Teranishi Y; Shiraso S; Kono K; Hori S; Kamiga T; Iwao T; Yamashita N
J Surg Oncol; 2022 Mar; 125(4):615-620. PubMed ID: 34985764
[TBL] [Abstract][Full Text] [Related]
7. Impact of preoperative chemotherapy as initial treatment for advanced gastric cancer with peritoneal metastasis limited to positive peritoneal lavage cytology (CY1) or localized peritoneal metastasis (P1a): a multi-institutional retrospective study.
Yamaguchi T; Takashima A; Nagashima K; Terashima M; Aizawa M; Ohashi M; Tanaka R; Yamada T; Kinoshita T; Matsushita H; Ishiyama K; Hosoda K; Yuasa Y; Haruta S; Kakihara N; Nishikawa K; Yunome G; Satoh T; Fukagawa T; Katai H; Boku N
Gastric Cancer; 2021 May; 24(3):701-709. PubMed ID: 33179192
[TBL] [Abstract][Full Text] [Related]
8. Is curative gastrectomy justified for gastric cancer with cytology positive as the only stage IV factor?
Komatsu S; Shioaki Y; Furuke H; Ohta A; Tsuji R; Tanaka S; Kumano T; Imura KI; Shimomura K; Ikeda J; Taniguchi F; Ueshima Y; Lee CJ; Deguchi E; Ikeda E; Otsuji E
Langenbecks Arch Surg; 2019 Aug; 404(5):599-604. PubMed ID: 31073759
[TBL] [Abstract][Full Text] [Related]
9. [Clinical significance and efficacy of conversion surgery for patients with stage IV gastric cancer].
Zhu Z
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Oct; 21(10):1087-1092. PubMed ID: 30370504
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of cytological status of peritoneal lavage fluid during intraperitoneal chemotherapy for gastric cancer with overt peritoneal dissemination.
Emoto S; Kitayama J; Ishigami H; Yamaguchi H; Watanabe T
Ann Surg Oncol; 2015 Mar; 22(3):780-6. PubMed ID: 25216603
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of Postoperative Chemotherapy After Resection that Leaves No Macroscopically Visible Disease of Gastric Cancer with Positive Peritoneal Lavage Cytology (CY1) or Localized Peritoneum Metastasis (P1a): A Multicenter Retrospective Study.
Yamaguchi T; Takashima A; Nagashima K; Makuuchi R; Aizawa M; Ohashi M; Tashiro K; Yamada T; Kinoshita T; Hata H; Kawachi Y; Kawabata R; Tsuji T; Hihara J; Sakamoto T; Fukagawa T; Katai H; Higuchi K; Boku N
Ann Surg Oncol; 2020 Jan; 27(1):284-292. PubMed ID: 31535301
[TBL] [Abstract][Full Text] [Related]
12. The survival and prognosticators of peritoneal cytology-positive gastric cancer patients who received upfront gastrectomy and subsequent S-1 chemotherapy.
Kano K; Aoyama T; Maezawa Y; Nakajima T; Ikeda K; Yamada T; Sato T; Oshima T; Rino Y; Masuda M; Ogata T; Cho H; Yoshikawa T
Int J Clin Oncol; 2017 Oct; 22(5):887-896. PubMed ID: 28456896
[TBL] [Abstract][Full Text] [Related]
13. [Treatment strategy for patients with CY1 gastric cancer using subgroup analyses].
Nagata H; Komatsu S; Ichikawa D; Kubota T; Okamoto K; Shiozaki A; Fujiwara H; Konishi H; Morimura R; Murayama Y; Kuriu Y; Ikoma H; Nakanishi M; Sakakura C; Otsuji E
Gan To Kagaku Ryoho; 2014 Nov; 41(12):2235-8. PubMed ID: 25731481
[TBL] [Abstract][Full Text] [Related]
14. Observational Study of Peritoneal Washing Cytology-Positive Gastric Cancer without Gross Peritoneal Metastasis in Patients who Underwent Radical D2 Gastrectomy.
Shim HJ; Kim HJ; Lee SH; Bae WK; Hwang EC; Cho SH; Chung IJ; Bang HJ; Hwang JE
Sci Rep; 2020 Jun; 10(1):9549. PubMed ID: 32533084
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors for cytology-positive gastric cancer.
Endo S; Ikenaga M; Ohta K; Ueda M; Tsuda Y; Kato R; Itakura H; Matsuyama J; Nishikawa K; Yamada T
Surg Today; 2019 Jan; 49(1):56-64. PubMed ID: 30167924
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of peritoneal lavage cytology at three cavities in patients with gastric cancer.
Kano Y; Kosugi S; Ishikawa T; Otani T; Muneoka Y; Sato Y; Hanyu T; Hirashima K; Bamba T; Wakai T
Surgery; 2015 Dec; 158(6):1581-9. PubMed ID: 25958064
[TBL] [Abstract][Full Text] [Related]
17. Significance of lavage cytology in advanced gastric cancer patients.
Fukagawa T; Katai H; Saka M; Morita S; Sasajima Y; Taniguchi H; Sano T; Sasako M
World J Surg; 2010 Mar; 34(3):563-8. PubMed ID: 20054543
[TBL] [Abstract][Full Text] [Related]
18. Gastric cancer with positive peritoneal cytology: survival benefit after induction chemotherapy and conversion to negative peritoneal cytology.
Valletti M; Eshmuminov D; Gnecco N; Gutschow CA; Schneider PM; Lehmann K
World J Surg Oncol; 2021 Aug; 19(1):245. PubMed ID: 34404403
[TBL] [Abstract][Full Text] [Related]
19. [Therapeutic strategy for gastric cancer with positive peritoneal lavage cytology without peritoneal dissemination].
Iwasaki Y; Ohashi M; Iwanaga T; Oohinata R; Yuu K; Takahashi K; Yamaguchi T; Matsumoto H; Nakano D
Gan To Kagaku Ryoho; 2012 Dec; 39(13):2451-4. PubMed ID: 23235163
[TBL] [Abstract][Full Text] [Related]
20. Reduced preoperative serum albumin and absence of peritoneal dissemination may be predictive factors for long-term survival with advanced gastric cancer with positive cytology test.
Yamashita K; Ushiku H; Katada N; Hosoda K; Moriya H; Mieno H; Kikuchi S; Hoshi K; Watanabe M
Eur J Surg Oncol; 2015 Oct; 41(10):1324-32. PubMed ID: 26251341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
